This story first appeared in “Go West,” STAT’s weekly newsletter about West Coast life sciences, health care, and biotech. Sign up here to receive it in your inbox.
SAN FRANCISCO — There’s a high-stakes fight in California that could shape the way that academic research gets read and published far beyond the West Coast.
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
About the Author
